{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Coenzyme Q10", "Cognitive impairment", "Diabetes", "Mitochondria", "Myopathy", "Respiratory chain", "SAMS", "Statin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33511728", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.1002/jcsm.12654"], "Journal": {"ISSN": "2190-6009", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Apr"}}, "Title": "Journal of cachexia, sarcopenia and muscle", "ISOAbbreviation": "J Cachexia Sarcopenia Muscle"}, "ArticleTitle": "Effects of statins on mitochondrial pathways.", "Pagination": {"StartPage": "237", "EndPage": "251", "MedlinePgn": "237-251"}, "Abstract": {"AbstractText": ["Statins are a family of drugs that are used for treating hyperlipidaemia with a recognized capacity to prevent cardiovascular disease events. They inhibit \u03b2-hydroxy \u03b2-methylglutaryl-coenzyme A reductase, i.e. the rate-limiting enzyme in mevalonate pathway, reduce endogenous cholesterol synthesis, and increase low-density lipoprotein clearance by promoting low-density lipoprotein receptor expression mainly in the hepatocytes. Statins have pleiotropic effects including stabilization of atherosclerotic plaques, immunomodulation, anti-inflammatory properties, improvement of endothelial function, antioxidant, and anti-thrombotic action. Despite all beneficial effects, statins may elicit adverse reactions such as myopathy. Studies have shown that mitochondria play an important role in statin-induced myopathies. In this review, we aim to report the mechanisms of action of statins on mitochondrial function. Results have shown that statins have several effects on mitochondria including reduction of coenzyme Q10 level, inhibition of respiratory chain complexes, induction of mitochondrial apoptosis, dysregulation of Ca<sup>2+</sup> metabolism, and carnitine palmitoyltransferase-2 expression. The use of statins has been associated with the onset of additional pathological conditions like diabetes and dementia as a result of interference with mitochondrial pathways by various mechanisms, such as reduction in mitochondrial oxidative phosphorylation, increase in oxidative stress, decrease in uncoupling protein 3 concentration, and interference in amyloid-\u03b2 metabolism. Overall, data reported in this review suggest that statins may have major effects on mitochondrial function, and some of their adverse effects might be mediated through mitochondrial pathways."], "CopyrightInformation": "\u00a9\u00a02021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders."}, "AuthorList": [{"Identifier": ["0000-0002-8157-5732"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Tavana", "ForeName": "Erfan", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Sciences, University of Turin, Turin, Italy."}], "LastName": "Fanni", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Sciences, AOU Citt\u00e0 della Salute e della Scienza di Torino, University of Turin, Turin, Italy."}], "LastName": "Bo", "ForeName": "Simona", "Initials": "S"}, {"Identifier": ["0000-0001-6690-6874"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Lodz, Poland."}, {"Identifier": [], "Affiliation": "Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland."}], "LastName": "Banach", "ForeName": "Maciej", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Medicine, University of Perugia, Perugia, Italy."}], "LastName": "Pirro", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology and Pneumology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."}, {"Identifier": [], "Affiliation": "German Center for Cardiovascular Research (DZHK), partner site G\u00f6ttingen, G\u00f6ttingen, Germany."}], "LastName": "von Haehling", "ForeName": "Stephan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Technology, Islamic Azad University, Quchan, Quchan, Iran."}, {"Identifier": [], "Affiliation": "Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jamialahmadi", "ForeName": "Tannaz", "Initials": "T"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Halal Research Center of IRI, FDA, Tehran, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Cachexia Sarcopenia Muscle", "NlmUniqueID": "101552883", "ISSNLinking": "2190-5991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Mitochondria"}, {"QualifierName": [], "DescriptorName": "Oxidative Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}], "CoiStatement": "Dr M.B. has served on the speakers bureau of Abbott/Mylan, Abbott Vascular, Actavis, Akcea, Amgen, Biofarm, KRKA, MSD, Sanofi\u2010Aventis, Servier, and Valeant and has served as a consultant to Abbott Vascular, Akcea, Amgen, Daichii Sankyo, Esperion, Lilly, MSD, Resverlogix, and Sanofi\u2010Aventis; he also received grants from Sanofi and Valeant. S.v.H. has been a paid consultant for and/or received honoraria payments from Bayer, Boehringer Ingelheim, BRAHMS, Chugai, Gr\u00fcnenthal, Helsinn, Hexal, ovartis, Respicardia, Roche, Sorin, and Vifor; owns shares in Actimed. SvH; and reports research support from IMI and the German Center for Cardiovascular Research (DZHK). Other authors have no competing interests to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors. J Am Coll Cardiol 2019;74:2529\u20132532.", "ArticleIdList": ["31727292"]}, {"Citation": "Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1659\u20131724.", "ArticleIdList": ["PMC5388856", "27733284"]}, {"Citation": "Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep 2012;14:1\u201310.", "ArticleIdList": ["PMC3697085", "22102062"]}, {"Citation": "Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low\u2010density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017;38:2459\u20132472.", "ArticleIdList": ["PMC5837225", "28444290"]}, {"Citation": "Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD. Effect of naturally random allocation to lower low\u2010density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both. J Am Coll Cardiol 2015;65:1552\u20131561.", "ArticleIdList": ["PMC6101243", "25770315"]}, {"Citation": "Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag 2008;4:341\u2013353.", "ArticleIdList": ["PMC2496987", "18561510"]}, {"Citation": "Franklin BA, Durstine JL, Roberts CK, Barnard RJ. Impact of diet and exercise on lipid management in the modern era. Best Pract Res Clin Endocrinol Metab 2014;28:405\u2013421.", "ArticleIdList": ["24840267"]}, {"Citation": "Pirro M, Vetrani C, Bianchi C, Mannarino MRR, Bernini F, Rivellese AAA. Joint position statement on \u201cNutraceuticals for the treatment of hypercholesterolemia\u201d of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). Nutr Metab Cardiovasc Dis 2017;27:2\u201317.", "ArticleIdList": ["27956024"]}, {"Citation": "Bianconi V, Mannarino MR, Sahebkar A, Cosentino T, Pirro M. Cholesterol\u2010lowering nutraceuticals affecting vascular function and cardiovascular disease risk. Curr Cardiol Rep 2018;20:53.", "ArticleIdList": ["29802549"]}, {"Citation": "Pirro M, Mannarino MR, Bianconi V, Simental\u2010Mend\u00eda LE, Bagaglia F, Mannarino E, et al. The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta\u2010analysis of randomized controlled trials. Pharmacol Res 2016;110:76\u201388.", "ArticleIdList": ["27157250"]}, {"Citation": "Johnston TP, Korolenko TA, Pirro M, Sahebkar A. Preventing cardiovascular heart disease: promising nutraceutical and non\u2010nutraceutical treatments for cholesterol management. Pharmacol Res 2017;120:219\u2013225.", "ArticleIdList": ["28408313"]}, {"Citation": "Sahebkar A, Simental\u2010Mend\u00eda LE, Reiner \u017d, Kovanen PT, Simental\u2010Mend\u00eda M, Bianconi V, et al. Effect of orlistat on plasma lipids and body weight: a systematic review and meta\u2010analysis of 33 randomized controlled trials. Pharmacol Res 2017;122:53\u201365.", "ArticleIdList": ["28559211"]}, {"Citation": "Endo A, Kuroda M, Tsujita Y. ML\u2010236A, ML\u2010236B, and ML\u2010236C, new inhibitors of cholesterogensis produced by penicillium citrinum. J Antibiot (Tokyo) 1976;29:1346\u20131348.", "ArticleIdList": ["1010803"]}, {"Citation": "Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med 2001;5:378\u2013387.", "ArticleIdList": ["PMC6740083", "12067471"]}, {"Citation": "Golomb BA, Evans MA. Statin adverse effects. Am J Cardiovasc Drugs 2008;8:373\u2013418.", "ArticleIdList": ["PMC2849981", "19159124"]}, {"Citation": "Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen. J Thromb Haemost 2016;115:03:520\u2013532. 10.1160/th15-08-0620", "ArticleIdList": ["10.1160/th15-08-0620", "26632869"]}, {"Citation": "Afshari AR, Mollazadeh H, Henney NC, Jamialahmad T, Sahebkar A. Effects of statins on brain tumors: a review. Sem Cancer Biol 2020. 10.1016/j.semcancer.2020.08.002", "ArticleIdList": ["10.1016/j.semcancer.2020.08.002", "32814114"]}, {"Citation": "Bagheri H, Ghasemi F, Barreto GE, Sathyapalan T, Jamialahmadi T, Sahebkar A. The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review. BioFactors 2020;46:3:309\u2013325. 10.1002/biof.1597", "ArticleIdList": ["10.1002/biof.1597", "31846136"]}, {"Citation": "Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour\u2010Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant\u2010antioxidant balance: results of a placebo\u2010controlled cross\u2010over trial. Lipids 2011;46:333\u2013340.", "ArticleIdList": ["21207250"]}, {"Citation": "Chru\u015bciel P, Sahebkar A, Rembek\u2010Wieliczko M, Serban M\u2010C, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta\u2010analysis of 43 randomized controlled trial arms. Atherosclerosis 2016;253:194\u2013208.", "ArticleIdList": ["27498397"]}, {"Citation": "Mohammadzadeh N, Montecucco F, Carbone F, Xu S, Al\u2010Rasadi K, Sahebkar A. Statins: Epidrugs with effects on endothelial health? Eur J Clin Invest 2020;50:12. 10.1111/eci.13388", "ArticleIdList": ["10.1111/eci.13388", "32854143"]}, {"Citation": "Calabr\u00f2 P, Yeh ETH. The pleiotropic effects of statins. Curr Opin Cardiol 2005;20:541\u2013546.", "ArticleIdList": ["16234628"]}, {"Citation": "Ii M, Losordo DW. Statins and the endothelium. Vascul Pharmacol 2007;46:1\u20139.", "ArticleIdList": ["16920035"]}, {"Citation": "Blanco\u2010Colio LM, Tu\u00f1\u00f3n J, Mart\u00edn\u2010Ventura JL, Egido J. Anti\u2010inflammatory and immunomodulatory effects of statins. Kidney Int 2003;63:12\u201323.", "ArticleIdList": ["12472764"]}, {"Citation": "Stoll LL, McCormick ML, Denning GM, Weintraub NL. Antioxidant effects of statins. Drugs of Today 2004;40:975\u2013990.", "ArticleIdList": ["15645009"]}, {"Citation": "Mahley RW, Berson TP. Drug therapy for hypercholesterolemia and dyslipidemia. Goodman Gilman's Pharmacol Basis Ther 2006;933\u2013966."}, {"Citation": "Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacology 2012;64:102\u2013146.", "ArticleIdList": ["22106090"]}, {"Citation": "McTaggart F. Comparative pharmacology of rosuvastatin. Atheroscler Suppl 2003;4:9\u201314.", "ArticleIdList": ["12714032"]}, {"Citation": "Thompson PD, Panza G, Zaleski A, Taylor B. Statin\u2010associated side effects. J Am Coll Cardiol 2016;67:2395\u20132410.", "ArticleIdList": ["27199064"]}, {"Citation": "Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: a meta\u2010analysis. Can J Cardiol 2012;28:574\u2013580.", "ArticleIdList": ["22884278"]}, {"Citation": "Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta\u2010analysis. Ann Pharmacother 2010;44:1410\u20131421.", "ArticleIdList": ["PMC3641194", "20702755"]}, {"Citation": "Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long\u2010term statin therapy? Curr Atheroscler Rep 2013;15:291.", "ArticleIdList": ["PMC3534845", "23225173"]}, {"Citation": "Venturini CD, Engroff P, Ely LS, de Ara\u00fajo Zago LF, Schroeter G, Gomes I, et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics 2011;66:1867\u20131872.", "ArticleIdList": ["PMC3203957", "22086515"]}, {"Citation": "Apostolopoulou M, Corsini A, Roden M. The role of mitochondria in statin\u2010induced myopathy. Eur J Clin Invest 2015;45:745\u2013754.", "ArticleIdList": ["25991405"]}, {"Citation": "Auer J, Sinzinger H, Franklin BARRY, Berent R. Muscle\u2010 and skeletal\u2010related side\u2010effects of statins: tip of the iceberg? Eur J Prev Cardiol 2016;23:88\u2013110.", "ArticleIdList": ["25230981"]}, {"Citation": "Scott RS, Lintott CJ, Wilson MJ. Simvastatin and side effects. N Z Med J 1991;104:493\u2013495.", "ArticleIdList": ["1745460"]}, {"Citation": "Wierzbicki AS, Lumb PJ, Semra Y, Chik G, Christ ER, Crook MA. Atorvastatin compared with simvastatin\u2010based therapies in the management of severe familial hyperlipidaemias. QJM 1999;92:387\u2013394.", "ArticleIdList": ["10627888"]}, {"Citation": "Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin\u2010associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 2015;36:1012\u20131022.", "ArticleIdList": ["PMC4416140", "25694464"]}, {"Citation": "Thompson PD. In Thompson PD, Taylor BA, eds. The Clinical Presentation of Statin\u2010Associated Muscle Symptoms (SAMS). Cham: Springer; 2020. p 21\u201326."}, {"Citation": "Zaleski AL, Taylor BA, Thompson PD. Coenzyme Q10 as treatment for statin\u2010associated muscle symptoms\u2014a good idea, but \u2026. Adv Nutr 2018;9:519S\u2013523S.", "ArticleIdList": ["PMC6054172", "30032220"]}, {"Citation": "Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, et al. Effect of statins on skeletal muscle function. Circulation 2013;127:96\u2013103.", "ArticleIdList": ["PMC4450764", "23183941"]}, {"Citation": "Krishnan GM, Thompson PD. The effects of statins on skeletal muscle strength and exercise performance. Curr Opin Lipidol 2010;21:324\u2013328.", "ArticleIdList": ["20581676"]}, {"Citation": "Thompson PD, Clarkson P, Karas RH. Statin\u2010associated myopathy. JAMA 2003;289:1681\u20131690.", "ArticleIdList": ["12672737"]}, {"Citation": "Toth PP, Harper CR, Jacobson TA. Clinical characterization and molecular mechanisms of statin myopathy. Expert Rev Cardiovasc Ther 2008;6:955\u2013969.", "ArticleIdList": ["18666846"]}, {"Citation": "Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Eur J Intern Med 2015;26:82\u201388.", "ArticleIdList": ["25640999"]}, {"Citation": "McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 2006;97:S89\u2013S94.", "ArticleIdList": ["16581336"]}, {"Citation": "Pasternak RC, Smith SC, Bairey\u2010Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation 2002;106:1024\u20131028.", "ArticleIdList": ["12186811"]}, {"Citation": "Maji D, Shaikh S, Solanki D, Gaurav K. Safety of statins. Indian J Endocrinol Metab Med 2013;17:636. 10.4103/2230-8210.113754", "ArticleIdList": ["10.4103/2230-8210.113754", "PMC3743363", "23961479"]}, {"Citation": "Newman CB, Tobert JA. Statin\u2010related myopathy and rhabdomyolysis. Endocr Metab Med 2018;760\u2013774."}, {"Citation": "Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care 2016;20:135.", "ArticleIdList": ["PMC4908773", "27301374"]}, {"Citation": "Bindoff L. Mitochondria and the heart. Eur Heart J 2003;24:221\u2013224.", "ArticleIdList": ["12590900"]}, {"Citation": "Rich PR, Mar\u00e9chal A. The mitochondrial respiratory chain. Essays Biochem 2010;47:1\u201323.", "ArticleIdList": ["20533897"]}, {"Citation": "Brookes PS. Mitochondrial H+ leak and ROS generation: an odd couple. Free Radic Biol Med 2005;38:12\u201323.", "ArticleIdList": ["15589367"]}, {"Citation": "Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000;25:502\u2013508.", "ArticleIdList": ["11050436"]}, {"Citation": "Chan K, Truong D, Shangari N, O'Brien PJ. Drug\u2010induced mitochondrial toxicity. Expert Opin Drug Metab Toxicol 2005;1:655\u2013669.", "ArticleIdList": ["16863431"]}, {"Citation": "Arenas J, Fern\u00e1ndez\u2010Moreno MA, Molina JA, Fern\u00e1ndez V, Del Hoyo P, Campos Y, et al. Myoglobinuria and COX deficiency in a patient taking cerivastatin and gemfibrozil. Neurology 2003;60:124\u2013126.", "ArticleIdList": ["12525734"]}, {"Citation": "Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al. Statin\u2010associated myopathy with normal creatine kinase levels. Ann Intern Med 2002;137:581\u2013585.", "ArticleIdList": ["12353945"]}, {"Citation": "De Pinieux G, Chariot P, Ammi\u2010Sa\u00efd M, Louarn F, Lejonc JL, Astier A, et al. Lipid\u2010lowering drugs and mitochondrial function: effects of HMG\u2010CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol 2003;42:333\u2013337.", "ArticleIdList": ["PMC2042680", "8877024"]}, {"Citation": "Wu JS, Buettner C, Smithline H, Ngo LH, Greenman RL. Evaluation of skeletal muscle during calf exercise by 31\u2010phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle Nerve 2011;43:76\u201381.", "ArticleIdList": ["PMC3332539", "21171098"]}, {"Citation": "Liantonio A, Giannuzzi V, Cippone V, Camerino GM, Pierno S, Camerino DC. Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+\u2010release system. J Pharmacol Exp Ther 2007;321:626\u2013634.", "ArticleIdList": ["17293561"]}, {"Citation": "Asping M, Stride N, S\u00f8gaard D, Dohlmann TL, Helge JW, Dela F, et al. The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle\u2010aged males: the LIFESTAT study. Eur J Clin Pharmacol 2017;73:679\u2013687.", "ArticleIdList": ["28246888"]}, {"Citation": "Galtier F, Mura T, Raynaud de Mauverger E, Chevassus H, Farret A, Gagnol J\u2010P, et al. Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers. Toxicol Appl Pharmacol 2012;263:281\u2013286.", "ArticleIdList": ["22771848"]}, {"Citation": "Hou T, Li Y, Chen W, Heffner RR, Vladutiu GD. Histopathologic and biochemical evidence for mitochondrial disease among 279 patients with severe statin myopathy. J Neuromuscul Dis 2017;4:77\u201387.", "ArticleIdList": ["28269789"]}, {"Citation": "Marcoff L, Thompson PD. The role of coenzyme Q10 in statin\u2010associated myopathy. J Am Coll Cardiol 2007;49:2231\u20132237.", "ArticleIdList": ["17560286"]}, {"Citation": "Garrido\u2010Maraver J, Cordero MD, Oropesa\u2010\u00c1vila M, Fern\u00e1ndez Vega A, de la Mata M, Delgado Pav\u00f3n A, et al. Coenzyme Q10 therapy. Mol Syndromol 2014;5:187\u2013197.", "ArticleIdList": ["PMC4112525", "25126052"]}, {"Citation": "Sahebkar A, Simental\u2010Mend\u00eda LE, Stefanutti C, Pirro M. Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: a systematic review and meta\u2010analysis. Pharmacol Res 2016;105:198\u2013209.", "ArticleIdList": ["26836888"]}, {"Citation": "\u00c5berg F, Appelkvist EL, Dallner G, Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 1992;295:230\u2013234.", "ArticleIdList": ["1586151"]}, {"Citation": "Salviati L, Trevisson E, Doimo M, Navas P. Primary Coenzyme Q10 Deficiency. In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., eds. GeneReviews\u00ae. Seattle, WA: University of Washington; 2017."}, {"Citation": "Saha SP, Whayne TF. Coenzyme Q10 in human health: supporting evidence? South Med J 2016;109:17\u201321.", "ArticleIdList": ["26741866"]}, {"Citation": "Bouitbir J, Charles A\u2010L, Echaniz\u2010Laguna A, Kindo M, Daussin F, Auwerx J, et al. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC\u20101. Eur Heart J 2012;33:1397\u20131407.", "ArticleIdList": ["PMC3365271", "21775390"]}, {"Citation": "Kaufmann P, T\u00f6r\u00f6k M, Zahno A, Waldhauser KM, Brecht K, Kr\u00e4henb\u00fchl S. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci 2006;63:2415\u20132425.", "ArticleIdList": ["17013560"]}, {"Citation": "P\u00e4iv\u00e4 H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, et al. High\u2010dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 2005;78:60\u201368.", "ArticleIdList": ["16003294"]}, {"Citation": "du Souich P, Roederer G, Dufour R. Myotoxicity of statins: mechanism of action. Pharmacol Ther 2017;175:1\u201316.", "ArticleIdList": ["28223230"]}, {"Citation": "Laaksonen R, Jokelainen K, Laakso J, Sahi T, H\u00e4rk\u00f6nen M, Tikkanen MJ, et al. The effect of simvastatin treatment on natural antioxidants in low\u2010density lipoproteins and high\u2010energy phosphates and ubiquinone in skeletal muscle. Am J Cardiol 1996;77:851\u2013854.", "ArticleIdList": ["8623738"]}, {"Citation": "Laaksonen R, Jokelainen K, Sahi T, Tikkanen MJ, Himberg JJ. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short\u2010term simvastatin treatment in humans. Clin Pharmacol Ther 1995;57:62\u201366.", "ArticleIdList": ["7828383"]}, {"Citation": "Lamperti C, Naini AB, Lucchini V, Prelle A, Bresolin N, Moggio M, et al. Muscle coenzyme Q10 level in statin\u2010related myopathy. Arch Neurol 2005;62:1709\u20131712.", "ArticleIdList": ["16286544"]}, {"Citation": "Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, et al. Effects of coenzyme Q10 on statin\u2010induced myopathy: a meta\u2010analysis of randomized controlled trials. Mayo Clin Proc 2015;90:24\u201334.", "ArticleIdList": ["25440725"]}, {"Citation": "Qu H, Guo M, Chai H, Wang W, Gao Z, Shi D. Effects of coenzyme Q10 on statin\u2010induced myopathy: an updated meta\u2010analysis of randomized controlled trials. J Am Heart Assoc 2018;7:e009835.", "ArticleIdList": ["PMC6404871", "30371340"]}, {"Citation": "Schick BA, Laaksonen R, Frohlich JJ, P\u00e4iv\u00e4 H, Lehtim\u00e4ki T, Humphries KH, et al. Decreased skeletal muscle mitochondrial DNA in patients treated with high\u2010dose simvastatin. Clin Pharmacol Ther 2007;81:650\u2013653.", "ArticleIdList": ["17329991"]}, {"Citation": "Stringer HAJ, Sohi GK, Maguire JA, C\u00f4t\u00e9 HCF. Decreased skeletal muscle mitochondrial DNA in patients with statin\u2010induced myopathy. J Neurol Sci 2013;325:142\u2013147.", "ArticleIdList": ["23312852"]}, {"Citation": "Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ, Naples SP, Fletcher J, et al. Simvastatin impairs exercise training adaptations. J Am Coll Cardiol 2013;62:709\u2013714.", "ArticleIdList": ["PMC3745788", "23583255"]}, {"Citation": "Singla M, Rastogi A, Aggarwal AN, Bhat OM, Badal D, Bhansali A. Vitamin D supplementation improves simvastatin\u2010mediated decline in exercise performance: a randomized double\u2010blind placebo\u2010controlled study. J Diabetes 2017;9:1100\u20131106.", "ArticleIdList": ["28233459"]}, {"Citation": "Mullen PJ, Zahno A, Lindinger P, Maseneni S, Felser A, Kr\u00e4henb\u00fchl S, et al. Susceptibility to simvastatin\u2010induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt. Biochim Biophys Acta \u2013 Mol Cell Res 2011;1813:2079\u20132087.", "ArticleIdList": ["21839782"]}, {"Citation": "Bonifacio A, Sanvee GM, Bouitbir J, Kr\u00e4henb\u00fchl S. The AKT/mTOR signaling pathway plays a key role in statin\u2010induced myotoxicity. Biochim Biophys Acta \u2013 Mol Cell Res 2015;1853:1841\u20131849.", "ArticleIdList": ["25913013"]}, {"Citation": "Vaughan RA, Garcia\u2010Smith R, Bisoffi M, Conn CA, Trujillo KA. Ubiquinol rescues simvastatin\u2010suppression of mitochondrial content, function and metabolism: implications for statin\u2010induced rhabdomyolysis. Eur J Pharmacol 2013;711:1\u20139.", "ArticleIdList": ["23624330"]}, {"Citation": "Singh F, Zoll J, Duthaler U, Charles A\u2010L, Panajatovic MV, Laverny G, et al. PGC\u20101\u03b2 modulates statin\u2010associated myotoxicity in mice. Arch Toxicol 2019;93:487\u2013504.", "ArticleIdList": ["30511338"]}, {"Citation": "Liu A, Wu Q, Guo J, Ares I, Rodr\u00edguez J\u2010L, Mart\u00ednez\u2010Larra\u00f1aga M\u2010R, et al. Statins: adverse reactions, oxidative stress and metabolic interactions. Pharmacol Ther 2019;195:54\u201384.", "ArticleIdList": ["30321555"]}, {"Citation": "Kwak H\u2010B, Thalacker\u2010Mercer A, Anderson EJ, Lin C\u2010T, Kane DA, Lee N\u2010S, et al. Simvastatin impairs ADP\u2010stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes. Free Radic Biol Med 2012;52:198\u2013207.", "ArticleIdList": ["PMC3313473", "22080086"]}, {"Citation": "Sirvent P, Mercier J, Lacampagne A. New insights into mechanisms of statin\u2010associated myotoxicity. Curr Opin Pharmacol 2008;8:333\u2013338.", "ArticleIdList": ["18243052"]}, {"Citation": "Schirris TJJ, Renkema GH, Ritschel T, Voermans NC, Bilos A, van Engelen BGM, et al. Statin\u2010induced myopathy is associated with mitochondrial complex III inhibition. Cell Metab 2015;22:399\u2013407.", "ArticleIdList": ["26331605"]}, {"Citation": "Sirvent P, Bordenave S, Vermaelen M, Roels B, Vassort G, Mercier J, et al. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun 2005;338:1426\u20131434.", "ArticleIdList": ["16271704"]}, {"Citation": "Nakahara K, Kuriyama M, Sonoda Y, Yoshidome H, Nakagawa H, Fujiyama J, et al. Myopathy induced by HMG\u2010CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. Toxicol Appl Pharmacol 1998;152:99\u2013106.", "ArticleIdList": ["9772205"]}, {"Citation": "Schaefer WH, Lawrence JW, Loughlin AF, Stoffregen DA, Mixson LA, Dean DC, et al. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin\u2010induced skeletal myopathy in rats. Toxicol Appl Pharmacol 2004;194:10\u201323.", "ArticleIdList": ["14728975"]}, {"Citation": "Duncan AJ, Hargreaves IP, Damian MS, Land JM, Heales SJR. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment. Toxicol Mech Methods 2009;19:44\u201350.", "ArticleIdList": ["19778232"]}, {"Citation": "Murlasits Z, Rad\u00e1k Z. The effects of statin medications on aerobic exercise capacity and training adaptations. Sports Med 2014;44:1519\u20131530.", "ArticleIdList": ["25012079"]}, {"Citation": "Herminghaus A, Laser E, Schulz J, Truse R, Vollmer C, Bauer I, et al. Pravastatin and gemfibrozil modulate differently hepatic and colonic mitochondrial respiration in tissue homogenates from healthy rats. Cell 2019;8:983.", "ArticleIdList": ["PMC6769625", "31461874"]}, {"Citation": "Ramachandran R, Wierzbicki A. Statins, muscle disease and mitochondria. J Clin Med 2017;6:75.", "ArticleIdList": ["PMC5575577", "28757597"]}, {"Citation": "Sirvent P, Fabre O, Bordenave S, Hillaire\u2010Buys D, Raynaud De Mauverger E, Lacampagne A, et al. Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins. Toxicol Appl Pharmacol 2012;259:263\u2013268.", "ArticleIdList": ["22269104"]}, {"Citation": "Sirvent P, Mercier J, Vassort G, Lacampagne A. Simvastatin triggers mitochondria\u2010induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun 2005;329:1067\u20131075.", "ArticleIdList": ["15752763"]}, {"Citation": "Taha DA, De Moor CH, Barrett DA, Lee JB, Gandhi RD, Hoo CW, et al. The role of acid\u2010base imbalance in statin\u2010induced myotoxicity. Transl Res 2016;174:140\u2013160.e14.", "ArticleIdList": ["PMC4967449", "27083388"]}, {"Citation": "Skottheim IB, Gedde\u2010Dahl A, Hejazifar S, Hoel K, \u00c5sberg A. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. Eur J Pharm Sci 2008;33:317\u2013325.", "ArticleIdList": ["18294823"]}, {"Citation": "Nakahara K, Yada T, Kuriyama M, Osame M. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG\u2010CoA reductase inhibitors. Biochem Biophys Res Commun 1994;202:1579\u20131585.", "ArticleIdList": ["8060342"]}, {"Citation": "Hermann M, Bogsrud MP, Molden E, \u00c5sberg A, Mohebi BU, Ose L, et al. Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several\u2010fold in patients with atorvastatin\u2010induced myopathy. Clin Pharmacol Ther 2006;79:532\u2013539.", "ArticleIdList": ["16765141"]}, {"Citation": "Dirks AJ, Jones KM. Statin\u2010induced apoptosis and skeletal myopathy. Am J Physiol Physiol 2006;291:C1208\u2013C1212.", "ArticleIdList": ["16885396"]}, {"Citation": "Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004;53:S12\u2013S18.", "ArticleIdList": ["14749260"]}, {"Citation": "Sacher J, Weigl L, Werner M, Szegedi C, Hohenegger M. Delineation of myotoxicity induced by 3\u2010hydroxy\u20103\u2010methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther 2005;314:1032\u20131041.", "ArticleIdList": ["15914674"]}, {"Citation": "Bouitbir J, Singh F, Charles A\u2010L, Schlagowski A\u2010I, Bonifacio A, Echaniz\u2010Laguna A, et al. Statins trigger mitochondrial reactive oxygen species\u2010induced apoptosis in glycolytic skeletal muscle. Antioxid Redox Signal 2016;24:84\u201398.", "ArticleIdList": ["26414931"]}, {"Citation": "Hosseinzadeh A, Bahrampour Juybari K, Kamarul T, Sharifi AM. Protective effects of atorvastatin on high glucose\u2010induced oxidative stress and mitochondrial apoptotic signaling pathways in cultured chondrocytes. J Physiol Biochem 2019;75:153\u2013162.", "ArticleIdList": ["30796627"]}, {"Citation": "Novelli G, D'Apice MR. Protein farnesylation and disease. J Inherit Metab Dis 2012;35:917\u2013926.", "ArticleIdList": ["22307208"]}, {"Citation": "Guijarro C, Blanco\u2010Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, et al. 3\u2010Hydroxy\u20103\u2010methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998;83:490\u2013500.", "ArticleIdList": ["9734471"]}, {"Citation": "Johnson TE, Zhang X, Bleicher KB, Dysart G, Loughlin AF, Schaefer WH, et al. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. Toxicol Appl Pharmacol 2004;200:237\u2013250.", "ArticleIdList": ["15504460"]}, {"Citation": "Mutoh T, Kumano T, Nakagawa H, Kuriyama M. Involvement of tyrosine phosphorylation in HMG\u2010CoA reductase inhibitor\u2010induced cell death in L6 myoblasts. FEBS Lett 1999;444:85\u201389.", "ArticleIdList": ["10037153"]}, {"Citation": "Mutoh T, Kumano T, Nakagawa H, Kuriyama M. Role of tyrosine phosphorylation of phospholipase C \u03b31 in the signaling pathway of HMG\u2010CoA reductase inhibitor\u2010induced cell death of L6 myoblasts. FEBS Lett 1999;446:91\u201394.", "ArticleIdList": ["10100621"]}, {"Citation": "Vladutiu GD, Simmons Z, Isackson PJ, Tarnopolsky M, Peltier WL, Barboi AC, et al. Genetic risk factors associated with lipid\u2010lowering drug\u2010induced myopathies. Muscle Nerve 2006;34:153\u2013162.", "ArticleIdList": ["16671104"]}, {"Citation": "Oh J, Ban MR, Miskie BA, Pollex RL, Hegele RA. Genetic determinants of statin intolerance. Lipids Health Dis 2007;6:7.", "ArticleIdList": ["PMC1832194", "17376224"]}, {"Citation": "Rua\u00f1o G, Windemuth A, Wu AHB, Kane JP, Malloy MJ, Pullinger CR, et al. Mechanisms of statin\u2010induced myalgia assessed by physiogenomic associations. Atherosclerosis 2011;218:451\u2013456.", "ArticleIdList": ["PMC3224998", "21868014"]}, {"Citation": "Humm A, Pritsche E, Steinbacher S. Structure and reaction mechanism of l\u2010arginine:glycine amidinotransferase. Biol Chem 1997;193\u2013197.", "ArticleIdList": ["9165070"]}, {"Citation": "Mangravite LM, Engelhardt BE, Medina MW, Smith JD, Brown CD, Chasman DI, et al. A statin\u2010dependent QTL for GATM expression is associated with statin\u2010induced myopathy. Nature 2013;502:377\u2013380.", "ArticleIdList": ["PMC3933266", "23995691"]}, {"Citation": "Ballard KD, Thompson PD. Does reduced creatine synthesis protect against statin myopathy? Cell Metab 2013;18:773\u2013774.", "ArticleIdList": ["PMC3899594", "24315367"]}, {"Citation": "Floyd JS, Bis JC, Brody JA, Heckbert SR, Rice K, Psaty BM. GATM locus does not replicate in rhabdomyolysis study. Nature 2014;513:E1\u2013E3.", "ArticleIdList": ["PMC4230441", "25230668"]}, {"Citation": "Carr DF, Alfirevic A, Johnson R, Chinoy H, van Staa T, Pirmohamed M. GATM gene variants and statin myopathy risk. Nature 2014;513:E1\u2013E1.", "ArticleIdList": ["25230669"]}, {"Citation": "Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131\u2013149.", "ArticleIdList": ["9239539"]}, {"Citation": "Ghatak A, Faheem O, Thompson PD. The genetics of statin\u2010induced myopathy. Atherosclerosis 2010;210:337\u2013343.", "ArticleIdList": ["20042189"]}, {"Citation": "Chariot P, Abadia R, Agnus D, Danan C, Charpentier C, Gherasdi RK. Simvastatin\u2010induced rhabdomyolysis followed by a MELAS syndrome. Am J Med 1993;94:109\u2013110.", "ArticleIdList": ["8420287"]}, {"Citation": "Bonnefont JP, Djouadi F, Prip\u2010Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 2004;25:495\u2013520.", "ArticleIdList": ["15363638"]}, {"Citation": "Bhuiyan J, Seccombe DW. The effects of 3\u2010hydroxy\u20103\u2010methylglutaryl\u2010CoA reductase inhibition on tissue levels of carnitine and carnitine acyltransferase activity in the rabbit. Lipids 1996;31:867\u2013870.", "ArticleIdList": ["8869889"]}, {"Citation": "Phillips PS, Phillips CT, Sullivan MJ, Naviaux RK, Haas RH. Statin myotoxicity is associated with changes in the cardiopulmonary function. Atherosclerosis 2004;177:183\u2013188.", "ArticleIdList": ["15488882"]}, {"Citation": "Traustad\u00f3ttir T, Stock AA, Harman SM. High\u2010dose statin use does not impair aerobic capacity or skeletal muscle function in older adults. Age (Omaha) 2008;30:283\u2013291.", "ArticleIdList": ["PMC2585641", "19424852"]}, {"Citation": "Song M, Chen F, Li Y, Zhang L, Wang F, Qin R, et al. Trimetazidine restores the positive adaptation to exercise training by mitigating statin\u2010induced skeletal muscle injury. J Cachexia Sarcopenia Muscle 2018;9:106\u2013118.", "ArticleIdList": ["PMC5803604", "29152896"]}, {"Citation": "Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623\u20131630.", "ArticleIdList": ["12457784"]}, {"Citation": "Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C\u2010reactive protein. N Engl J Med 2008;359:2195\u20132207.", "ArticleIdList": ["18997196"]}, {"Citation": "Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta\u2010analysis of randomised statin trials. Lancet 2010;375:735\u2013742.", "ArticleIdList": ["20167359"]}, {"Citation": "Sadighara M, Joktaji J, Hajhashemi V, Minaiyan M. Protective effects of coenzyme Q 10 and L\u2010carnitine against statin\u2010induced pancreatic mitochondrial toxicity in rats. Res Pharm Sci 2017;12:434.", "ArticleIdList": ["PMC5691570", "29204172"]}, {"Citation": "Supale S, Li N, Brun T, Maechler P. Mitochondrial dysfunction in pancreatic \u03b2 cells. Trends Endocrinol Metab 2012;23:477\u2013487.", "ArticleIdList": ["22766318"]}, {"Citation": "Urbano F, Bugliani M, Filippello A, Scamporrino A, Di Mauro S, Di Pino A, et al. Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat \u03b2\u2010cells. Direct effect of oxidative stress. Sci Rep 2017;7:11863.", "ArticleIdList": ["PMC5605712", "28928397"]}, {"Citation": "Sadighara M, Amirsheardost Z, Minaiyan M, Hajhashemi V, Naserzadeh P, Salimi A, et al. Toxicity of atorvastatin on pancreas mitochondria: a justification for increased risk of diabetes mellitus. Basic Clin Pharmacol Toxicol 2017;120:131\u2013137.", "ArticleIdList": ["27553485"]}, {"Citation": "Yada T, Nakata M, Shiraishi T, Kakei M. Inhibition by simvastatin, but not pravastatin, of glucose\u2010induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L\u2010type Ca2+ channels in rat islet \u03b2\u2010cells. Br J Pharmacol 1999;126:1205\u20131213.", "ArticleIdList": ["PMC1565875", "10205010"]}, {"Citation": "Cederberg H, Stan\u010d\u00e1kov\u00e1 A, Yaluri N, Modi S, Kuusisto J, Laakso M. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow\u2010up study of the METSIM cohort. Diabetologia 2015;58:1109\u20131117.", "ArticleIdList": ["25754552"]}, {"Citation": "Ganesan S, Ito MK. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3\u2010L1 adipocytes. Metab Syndr Relat Disord 2013;11:251\u2013255.", "ArticleIdList": ["23496027"]}, {"Citation": "Moro C, Bajpeyi S, Smith SR. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Metab 2008;294:E203\u2013E213.", "ArticleIdList": ["18003718"]}, {"Citation": "Schrauwen P, Hesselink MKC, Blaak EE, Borghouts LB, Schaart G, Saris WHM, et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2001;50:2870\u20132873.", "ArticleIdList": ["11723073"]}, {"Citation": "Liu J, Li J, Li W\u2010J, Wang C\u2010M. The role of uncoupling proteins in diabetes mellitus. J Diabetes Res 2013;2013:1\u20137.", "ArticleIdList": ["PMC3687498", "23841103"]}, {"Citation": "Larsen S, Stride N, Hey\u2010Mogensen M, Hansen CN, Bang LE, Bundgaard H, et al. Simvastatin effects on skeletal muscle. J Am Coll Cardiol 2013;61:44\u201353.", "ArticleIdList": ["23287371"]}, {"Citation": "Sastre J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003;35:1\u20138.", "ArticleIdList": ["12826250"]}, {"Citation": "Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 2009;28:75\u201380.", "ArticleIdList": ["PMC2814023", "19648749"]}, {"Citation": "Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin\u2010associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003;23:871\u2013880.", "ArticleIdList": ["12885101"]}, {"Citation": "Rojas\u2010Fernandez CH, Cameron J\u2010CF. Is statin\u2010associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother 2012;46:549\u2013557.", "ArticleIdList": ["22474137"]}, {"Citation": "Muldoon MF, Ryan CM, Sereika SM, Flory JD, Manuck SB. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004;117:823\u2013829.", "ArticleIdList": ["15589485"]}, {"Citation": "Muldoon MF, Barger SD, Ryan CM, Flory JD, Lehoczky JP, Matthews KA, et al. Effects of lovastatin on cognitive function and psychological well\u2010being. Am J Med 2000;108:538\u2013546.", "ArticleIdList": ["10806282"]}, {"Citation": "Collins R, Armitage J, Parish S, Sleight P, Peto R. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high\u2010risk individuals: a randomised placebocontrolled trial. Lancet 2002;360:7\u201322.", "ArticleIdList": ["12114036"]}, {"Citation": "McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2016;2016.", "ArticleIdList": ["PMC9346344", "26727124"]}, {"Citation": "Rojas\u2010Fernandez CH, Goldstein LB, Levey AI, Taylor BA, Bittner V. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol 2014;8:S5\u2013S16.", "ArticleIdList": ["24793442"]}, {"Citation": "Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, et al. Do statins impair cognition? A systematic review and meta\u2010analysis of randomized controlled trials. J Gen Intern Med 2015;30:348\u2013358.", "ArticleIdList": ["PMC4351273", "25575908"]}, {"Citation": "Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS. Statins and cognition: a systematic review and meta\u2010analysis of short\u2010 and long\u2010term cognitive effects. Mayo Clin Proc 2013;88:1213\u20131221.", "ArticleIdList": ["24095248"]}, {"Citation": "Song Y, Nie H, Xu Y, Zhang L, Wu Y. Association of statin use with risk of dementia: a meta\u2010analysis of prospective cohort studies. Geriatr Gerontol Int 2013;13:817\u2013824.", "ArticleIdList": ["23461525"]}, {"Citation": "Schultz BG, Patten DK, Berlau DJ. The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms. Transl Neurodegener 2018;7:5.", "ArticleIdList": ["PMC5830056", "29507718"]}, {"Citation": "M\u00fcller WE, Eckert A, Kurz C, Eckert GP, Leuner K. Mitochondrial dysfunction: common final pathway in brain aging and alzheimer's disease\u2014therapeutic aspects. Mol Neurobiol 2010;41:159\u2013171.", "ArticleIdList": ["20461558"]}, {"Citation": "Li Y, Liu Q, Sun J, Wang J, Liu X, Gao J. Mitochondrial protective mechanism of simvastatin protects against amyloid \u03b2 peptide\u2010induced injury in SH\u2010SY5Y cells. Int J Mol Med 2018;41:2997\u20133005.", "ArticleIdList": ["29436584"]}, {"Citation": "Jeong J\u2010H, Yum KS, Chang JY, Kim M, Ahn J, Kim S, et al. Dose\u2010specific effect of simvastatin on hypoxia\u2010induced HIF\u20101\u03b1 and BACE expression in Alzheimer's disease cybrid cells. BMC Neurol 2015;15:127.", "ArticleIdList": ["PMC4521481", "26228060"]}, {"Citation": "von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019. J Cachexia Sarcopenia Muscle 2019;10:1143\u20131145.", "ArticleIdList": ["PMC6818444", "31661195"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "9"}, {"Year": "2020", "Month": "7", "Day": "1"}, {"Year": "2020", "Month": "10", "Day": "20"}, {"Year": "2021", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "29", "Hour": "6", "Minute": "4"}, {"Year": "2021", "Month": "4", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33511728", "PMC8061391", "10.1002/jcsm.12654"]}}], "PubmedBookArticle": []}